Amicus Therapeutics, Inc. (FOLD)
14.44
-0.02
(-0.14%)
USD |
NASDAQ |
Apr 01, 16:00
14.43
-0.01
(-0.07%)
After-Hours: 20:00
Amicus Therapeutics Research and Development Expense (TTM) : 135.84M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| BioMarin Pharmaceutical, Inc. | 700.97M |
| CorMedix, Inc. | 19.33M |
| Krystal Biotech, Inc. | 55.08M |
| MannKind Corp. | 66.35M |
| Keros Therapeutics, Inc. | 129.56M |